Articles On EMvision Medical Devices (ASX:EMV)
Title | Source | Codes | Date |
---|---|---|---|
Closing Bell: Iron ore, gold, energy stocks struggle; but Bitcoin is on fire
ASX 200 drops as gold, iron ore and energy stocks struggle Paladin shares plunge after cutting uranium output forecast Australian business confidence hits two-year high amid easing inflation The ASX 200 index slipped by 0.13% on Tuesday... |
Stockhead | EMV | 1 month ago |
Health Check: Hold the front page for a rush of clinical trial updates
Emvision expects to release trial results for its Emu stroke-detection device in November Syntara’s rare blood cancer program gathers pace Actinogen says 25 patients have been treated in its 200-candidate Alzheimer’s disease study Quart... |
Stockhead | EMV | 1 month ago |
Making money: How many microcaps should be in an investor’s portfolio?
In this interview Dale Gillham and small cap company director Rod North discuss what to look for in microcap stocks and what place they should have in an investor’s portfolio. They discuss success stories, risk vs reward, and, the challe... |
themarketonline.com.au | EMV | 1 month ago |
Health Check: Rats – and investors – are happy as Nyrada forges ahead with its first human brain injury trial
Nyrada to launch phase I first-in-human trial after passing preclinical safety studies Neuren Pharmaceuticals ‘mini me’ Percheron seeks funds for rare disease program Another win for Pro Medicus, this time locally Nyrada (ASX:NYR) share... |
Stockhead | EMV | 2 months ago |
Curvebeam’s “weight-bearing CT scanner” to gain more traction after FDA clearance
Curvebeam’s innovative products are revolutionising cone beam CT imaging The company’s HiRise offers weight-bearing CT scans directly to a surgeon’s office The enhanced HiRise has recently received FDA clearance The medical devices segm... |
Stockhead | EMV | 4 months ago |
EMVision unveils portable brain scanner for first responders
Founder-led medical technology company EMVision (ASX: EMV) has today unveiled its proof of concept device for a backpack-sized brain scanner to be used by first responders, which if successfully commercialised would allow paramedics to scan... |
businessnewsaustralia.com | EMV | 5 months ago |
Closing Bell: Rare earths hit launches 300pc small cap moon shot as ASX benchmark beards its bears
ASX in broad rebound; Cettire, Neuren, and Lendlease lead surge Positive sentiment follows Wall Street strength DY6 Metals up 300pc on Rare Earths find at the Tundulu project in Malawi Aussie shares rebounded pretty much across the boa... |
Stockhead | EMV | 6 months ago |
EMVision Medical Devices’ interim trial data shows promising results in identifying stroke types
Stage 2 interim data from a pre-validation trial by EMVision Medical Devices (ASX: EMV) has confirmed the positive performance of neurodiagnostic artificial intelligence (AI) algorithms in the diagnosis of suspected haemorrhagic or ischaemi... |
SmallCaps | EMV | 6 months ago |
ASX Health Stocks: EMV’s AI algo shows promise, and Telix submits new FDA application
EMVision’s AI algorithm shows promise EMvision Medical Devices (ASX:EMV) has shared an update from its ongoing clinical trials focusing on improving EMVision’s AI algorithms for diagnosing strokes caused by bleeding or blockages in the brai... |
Stockhead | EMV | 6 months ago |
Market Highlights: ASX to rebound after US survey; and 5 ASX small caps to watch today
ASX 200 set to rise Monday, following New York’s rally US traders optimistic after Michigan survey, easing inflation concerns Approval for Ether ETFs opens door for Blackrock, VanEck, and Ark 21Shares The ASX 200 is poised to rebou... |
Stockhead | EMV | 6 months ago |
EMVision Medical Devices secures strategic investment from US-based Keysight Technologies
Australian company EMVision Medical Devices (ASX:EMV) has secured a strategic $15.28 million investment via a placement to the long-standing investor in the company, Keysight Technologies. |
BiotechDispatch | EMV | 9 months ago |
ASX Health Stocks: EMV gets strategic US$15m investment from NYSE-listed giant
EMvision receives strategic investment from NYSE-listed firm Radiopharm doses first patient in Phase 1 pancreatic cancer trial EMVision receives investment from NYSE-listed Keysight EMVision Medical Devices (ASX:EMV) soared as high as 1... |
Stockhead | EMV | 9 months ago |
Market Highlights: New record in sight for Bitcoin, and 5 ASX small caps to watch on Thursday
ASX to open lower, tracking Wall Street Fed member sees rate cuts this year as inflation data looms Bitcoin pops to over US$60k, with more catalysts to come The ASX is poised to open lower on Thursday in line with losses on Wall Stre... |
Stockhead | EMV | 9 months ago |
TMH Market Close: ASX200 slumps 0.76pc as real estate drags, IT edges higher
So much for a small rise on the market today. Instead, the ASX200 closed down about three quarters (.76) per cent. Real estate stocks proved the biggest drag, down just over one and a quarter of a per cent, while IT was the only sector t... |
themarketherald.com.au | EMV | 1 year ago |
TMH Market Update: ASX200 retreats, Adore Beauty rebuffs bid, Liontown completes SPP
The ASX200 has been trading down more than .4 per of a per cent today. Information technology is the only sector in the green, adding nearly a per cent, while consumer discretionary is the poorest performer so far, down nearly 1.2 per... |
themarketherald.com.au | EMV | 1 year ago |
EMVision unveils first point-of-care brain scanner device at RSNA 2023
EMVision (ASX:EMV) reveals the name of its inaugural point-of-care brain scanner device, ’emu’, at the RSNA 2023 conference In parallel, the company has fully recruited 150 suspected stroke patients for stage two of its multi-site clinic... |
themarketherald.com.au | EMV | 1 year ago |
Allegra’s game-changing Spinal Cage device awaits FDA nod, as ASX medical device stocks make inroads
ASX medical devices to make inroads with FDA after a good year for drug developers FDA is reviewing Allegra’s Spinal Cage Device made from 3D-printed Sr-HT-Gahnite Stockhead reached out to Allegra’s board member, Dr Nick Hartnell It’s b... |
Stockhead | EMV | 1 year ago |
EMVision assembles second gen ultra-lightweight helmet scanner prototype for bench testing
EMVision Medical Devices (ASX:EMV) assembles an advanced 28-antenna prototype for its second-generation helmet scanner The ultra-lightweight helmet scanner is designed for use in road and air ambulance settings An ethics submission fo... |
themarketherald.com.au | EMV | 1 year ago |
ASX Health Stocks: Recce moves forward in Phase 1/2 study; EMV unveils Gen 2 helmet scanner for ambulance
Recce Pharma moves forward to stronger dose in Phase 1/2 trial EMV is bench testing its 2nd Gen ultra-light weight helmet scanner Recce Pharma moves forward to higher dosage Synthetic anti-infectives producer, Recce Pharmaceuticals (ASX... |
Stockhead | EMV | 1 year ago |
ASX Health Stocks: Paradigm to seek TGA nod after successful trial; EMVision uses AI simulation
Paradigm Biopharma set to submit application to TGA EMVision uses artificial intelligence simulation Paradigm to submit TGA application after successful trial Paradigm Biopharmaceuticals (ASX:PAR) jumped 13% this morning after reporting... |
Stockhead | EMV | 1 year ago |
Market Highlights: Gold, oil and defence stocks advance on Wall Street; and 5 ASX small caps to watch today
Shares to rise for third day in a row Wall Street lifted after comments from Fed official Gold and oil stocks continued to climb on the back of Middle East fallout Aussie shares are poised to rise for the third day in a row today. At 8a... |
Stockhead | EMV | 1 year ago |
Curvebeam AI CEO says medical devices beat drugs to revenue, massive market in medical imaging
Medical devices offer faster route to commercialisation than drugs How newly listed Curvebeam AI aims to grab market share Stockhead reached out to Curvebeam AI CEO, Greg Brown Despite the recent rally, the ASX Healthcare Index (XHJ) is... |
Stockhead | EMV | 1 year ago |
Strokes cost the Australian economy billions, but these biotech players could change that
Stroke has long been recognised as being among Australia’s most costly disease groups. It occurs when a blood vessel supplying blood to the brain either suddenly becomes blocked or ruptures and begins to bleed which can result in part of t... |
Stockhead | EMV | 1 year ago |
EMVision Medical Devices (ASX:EMV) progresses clinical trial; triggers $600k milestone payment
EMVision Medical Devices (EMV) reports all three of its clinical trial sites are now enrolling The Princess Alexandra Hospital sites in Brisbane are now live with the company reporting “excellent” maintenance of enrolment levels The c... |
themarketherald.com.au | EMV | 1 year ago |
EMVision says clinical trial progressing and ASA milestone achieved
EMVision Medical Devices (ASX:EMV), which is developing portable brain imaging for stroke, has announced the third and final clinical trial site for its Gen 1 device, enabling faster detection and diagnosis of stroke. |
BiotechDispatch | EMV | 1 year ago |
Market Highlights: Fed’s foggy interest rates path; and ‘AI’ mentioned over 1,000 times in earnings calls
Shares to open flat after the Fed bumped rates another 25bp Google, Microsoft and Meta reported earnings The word AI was mentioned over 1,000 times in the earnings reports Local shares are set to open flat on Thursday after a mixed sess... |
Stockhead | EMV | 1 year ago |
EMVision Medical Devices receives progress payment under manufacturing grant
EMVision Medical Devices (ASX:EMV) has received a cash progress payment of $1,750,000 under its Modern Manufacturing Initiative grant award. |
BiotechDispatch | EMV | 1 year ago |
EMVision founder appointed CEO as portable brain scanner company enters Stage 2 clinical trial
EMVision (ASX: EMV) founder Scott Kirkland will step into the CEO role from 1 July, succeeding Dr Ron Weinberger who joined the portable brain scanner company five years ago after a 13-year stint in leadership roles at Nanosonics (ASX: NAN)... |
businessnewsaustralia.com | EMV | 1 year ago |
EMVision Medical Devices (ASX:EMV) activates stage two trial for its portable brain scanner
EMVision Medical Devices (EMV) activates stage two of the multi-site trial for its first-generation portable brain scanner Stage two will see EMV enrol 150 acute stroke and stroke-mimic patients across major medical centres in Australia... |
themarketherald.com.au | EMV | 1 year ago |
Market Highlights: ASX to rally on debt ceiling deal, as another US chipmaker surges over 30pc
The ASX is set to rise on Monday on a relief rally Another chipmaker, Marvell, surges 32pc Shaq O’Neal served court papers for doing FTX ads Aussie shares are set to rally on Monday after the White House and Republicans reached a tentat... |
Stockhead | EMV | 1 year ago |
EMVision Medical Devices (ASX:EMV) completes stage one brain scan trial enrolment
EMVision Medical Devices (EMV) completes the enrolment of 30 healthy volunteers into its stage one clinical trial for its brain scanning tech The company is looking to test its portable EMVision brain scanner device, which obtains images... |
themarketherald.com.au | EMV | 1 year ago |
EmVision Medical Devices (ASX:EMV) progresses clinical trial with 50pc patient enrolment
EMVision Medical Devices (EMV) completes enrolment of around half the 30 participants required for its stage one clinical trial for stroke monitoring The company told investors its pre-validation phase of the clinical trial is on schedul... |
themarketherald.com.au | EMV | 1 year ago |
EMVision’s (ASX:EMV) multi-centre clinical trial begins
EMVision Medical Devices (EMV) begins the multi-centre clinical trial of its brain scanner deviceFollowing user training at the Liverpool Hospital in Sydney, enrolment of a planned 30 healthy volunteers has begunMoving forward, stage two of... |
themarketherald.com.au | EMV | 2 years ago |
ASX Health Stocks: Little Green Pharma closing in on first over-the-counter CBD product in Australia
Little Green Pharma gets ethics approval to commence Phase 3 trial EMVision has commenced a clinical trial Little Green Pharma to start Phase 3 trial Cannabis company Little Green Pharma (ASX:LGP) has secured Human Research Ethics Appro... |
Stockhead | EMV | 2 years ago |
Market Highlights: iPhones shortage, Fed Powell to speak, and 5 ASX small caps to watch today
The ASX will open lower on Wednesday, tracking Wall Street Apple has lost US$165 billion of market cap in the last few days Fed Chair Jerome Powell expected to speak later tonight The ASX is set to open lower on Wednesday, tracking the... |
Stockhead | EMV | 2 years ago |
ASX Health Stocks: EMV jumps 7pc after delivering portable brain scanner; Firebrick gets Aussie patent
EMV Medical Devices delivered its first portable brain scanner Firebrick Pharma gets patent in Australia Antisense to progress on clinical trial EMVision delivers first brain scanner EMVision Medical Devices (ASX:EMV) jumped 7% after anno... |
Stockhead | EMV | 2 years ago |
EMVision Medical (ASX:EMV) delivers portable brain scanner to first clinical site for stroke trial
EMVision medical (EMV) delivers a portable brain scanner to the first clinical site in its multi-centre trial to treat strokesThe fully commissioned, first Gen scanner has been delivered to Liverpool Hospital in Melbourne – the first of mul... |
themarketherald.com.au | EMV | 2 years ago |
Market Highlights: Tech stocks rise, cryptos slide, and 5 ASX small caps to watch on Monday
The ASX is set to rally again on Monday Wall Street gained for two straight sessions since the inflation report Cryptos continue slide Local shares are set to start the week on a high note after another rally in New York. At 8.30am AEDT,... |
Stockhead | EMV | 2 years ago |
Market surges to a five-month high after a shaky week: ASX up 2.68% at noon
ShareCafeMarket surges to a five-month high after a shaky week: ASX up 2.68% at noon by Peter Milios The ASX has opened to a five-month high, as Information Technology surged by almost 5 per cent. Real Estate was the next best sector, clo... |
ShareCafe | EMV | 2 years ago |
Stocks of the Hour: EMV, VMS, TKM
ShareCafeStocks of the Hour: EMV, VMS, TKM EMVision Medical Devices (ASX:EMV), a company that develops medical imaging technology, has today announced that they have been awarded a $2.5 million non-dilutive grant fr... |
ShareCafe | EMV | 2 years ago |
Stocks of the Hour: EMVision, Venture Minerals, Trek Metals
11 Nov 2022 - A snapshot of the stocks on the move featuring EMVision (ASX:EMV), Venture Minerals (ASX:VMS) and Trek Metals (ASX:TKM). |
FNN | EMV | 2 years ago |
EMVision (ASX:EMV) backed by NSW Medical Devices Fund with $2.5m grant
EMVision Medical Devices (EMV) is set to pocket a $2.5 million grant from the New South Wales Medical Devices FundThe fund supports the development of innovations to market and increases the uptake of NSW medical devices by the health syste... |
themarketherald.com.au | EMV | 2 years ago |
EMVision Medical (ASX:EMV) awarded $5m government grant
EMVision Medical Devices (EMV) locks in $5 million in funding for the development and commercialisation of its portable brain scanner productThe company will receive the non-dilutive funds under the Federal Department of Industry, Science a... |
themarketherald.com.au | EMV | 2 years ago |
Market Highlights: Wall St momentum, another British PM, and 5 ASX small caps to watch today
ASX to track Wall St higher on Tuesday Rishi Sunak poised to become next British PM Jim Chalmers will deliver the Fed Budget at 7.30pm AEDT Local shares are set to open higher again on Tuesday, tracking the gains in New York. At 8am AEST,... |
Stockhead | EMV | 2 years ago |
EMVision Medical (ASX:EMV) receives ethics approval for multi-centre clinical trial
EMVision (EMV) receives human research ethics committee (HREC) approval for its multi-centre Brain Scanner clinical study aiming to treat strokes in AustraliaThe company says the approval is confirmation it has met the necessary safety test... |
themarketherald.com.au | EMV | 2 years ago |
Market Highlights: Weak data excites Wall St, RBA’s call, and 5 ASX small caps to watch today
The ASX will open much higher on Tuesday Wall St came back from the ashes overnight, up by 2.5% RBA decision at 2.30pm AEDT today Local shares are poised to open higher on Tuesday. At 8am AEST, the ASX 200 October futures contract was poi... |
Stockhead | EMV | 2 years ago |
3 ASX shares soaring on earnings updates
Earnings season is starting to slow down but thereâs still plenty of excitement for those interested in finding it. Take these three ASX shares for example. Theyâre each leaping higher on Tuesday on the back of earnings announcements.... |
Motley Fool | EMV | 2 years ago |
Closing Bell: Small caps licked in 3% rout as pot stock delivers ASX-first pot stock dividend!
Local markets follow Wall St ‘hopetimism’ lower Small caps smashed, down circa 3% Pot stock CAU delivers ASX first ever pot stock profit The Benchmark is down 1.95% and the small caps index is down 2.7% after climbing late in the session... |
Stockhead | EMV | 2 years ago |
ASX 200 falls 1.95%; all 11 sectors end in red; IT plunges 4.5%
Highlights The ASX 200 benchmark index closed lower today (29 August), losing 138.60 points or 1.95% to end at 6,965.50 points. Over the last five days, the index has lost 1.16% and 6.98% over the last 52 weeks. IT was the worst perfo... |
Kalkine Media | EMV | 2 years ago |
EMVision Medical Devices (ASX:EMV) to receive $5m MMI grant
EMVision Medical Devices (EMV) will receive a grant under the Modern Manufacturing Initiative (MMI) program by the Department of Industry, Science, Energy and Resources The medical device company is awarded $5 million under the MMI Manufac... |
themarketherald.com.au | EMV | 2 years ago |